Long-term follow-up of a phase 2 study of chemotherapy plus dasatinib for the initial treatment of patients with Philadelphia chromosome-positive acute lymphoblastic leukemia-Reference-Cited by-同舟云学术

Long-term follow-up of a phase 2 study of chemotherapy plus dasatinib for the initial treatment of patients with Philadelphia chromosome-positive acute lymphoblastic leukemia

Published:2015-08-26 Issue:23 Volume:121 Page:4158-4164
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Ravandi Farhad¹,O'Brien Susan M.¹,Cortes Jorge E.¹,Thomas Deborah M.¹,Garris Rebecca¹,Faderl Stefan¹,Burger Jan A.¹,Rytting Michael E.¹,Ferrajoli Alessandra¹,Wierda William G.¹,Verstovsek Srdan¹,Champlin Richard²,Kebriaei Partow²,McCue Deborah A.³,Huang Xuelin⁴,Jabbour Elias¹,Garcia-Manero Guillermo¹,Estrov Zeev¹,Kantarjian Hagop M.¹

Affiliation:

1. Department of Leukemia; The University of Texas MD Anderson Cancer Center; Houston Texas

2. Department of Cellular Therapy and Stem Cell Transplantation; The University of Texas MD Anderson Cancer Center; Houston Texas

3. Department of Pharmacy; The University of Texas MD Anderson Cancer Center; Houston Texas

4. Department of Biostatistics; The University of Texas MD Anderson Cancer Center; Houston Texas

Funder

Bristol-Myers Squibb

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.29646/fullpdf

Reference23 articles.

1. Improved survival in chronic myeloid leukemia since the introduction of imatinib therapy: a single-institution historical experience;Kantarjian;Blood.,2012

2. Advances in the management of Ph-positive ALL;Hoelzer;Clin Adv Hematol Oncol.,2006

3. A phase 2 study of imatinib in patients with relapsed or refractory Philadelphia chromosome-positive acute lymphoid leukemias;Ottmann;Blood.,2002

4. Dasatinib induces rapid hematologic and cytogenetic responses in adult patients with Philadelphia chromosome positive acute lymphoblastic leukemia with resistance or intolerance to imatinib:interim results of a phase 2 study;Ottmann;Blood.,2007

5. Treatment of Philadelphia chromosome-positive acute lymphocytic leukemia with hyper-CVAD and imatinib mesylate;Thomas;Blood.,2004

Cited by 167 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diagnostic and therapeutic advances in adults with acute lymphoblastic leukemia in the era of gene analysis and targeted immunotherapy;The Korean Journal of Internal Medicine;2024-01-01

2. Recommendations for the treatment and management of adult B‐Cell acute lymphoblastic leukemia in Asia‐Pacific: Outcomes from a pilot initiative;Asia-Pacific Journal of Clinical Oncology;2023-12-26

3. How to Manage Philadelphia-Positive Acute Lymphoblastic Leukemia in Resource-Constrained Settings;Cancers;2023-12-10

4. SOHO State of the Art Updates and Next Questions: Update on the Approach to Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia;Clinical Lymphoma Myeloma and Leukemia;2023-12

5. Prognostic Impact of Copy Number Alterations’ Profile and AID/RAG Signatures in Acute Lymphoblastic Leukemia (ALL) with BCR::ABL and without Recurrent Genetic Aberrations (NEG ALL) Treated with Intensive Chemotherapy;Cancers;2023-11-15